Kapiʻolani Medical Center for Women and Children is part of Hawaii Pacific Health's network of hospitals. It is located in Honolulu, Hawaii, within the residential inner-city district of Makiki.

There are 243 beds in Kapiolani Medical Center for Women and Children.

During the past decade, Kapiolani Medical Center for Women and Children conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 161 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 77 clinical trials were completed. i.e. 145.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kapiolani Medical Center for Women and Children" #1 sponsor was "National Cancer Institute (NCI)" with 135 trials, followed by "Children's Oncology Group" with 62 trials sponsored, "SWOG Cancer Research Network" with 55 trials sponsored, "Alliance for Clinical Trials in Oncology" with 43 trials sponsored and "Wake Forest University Health Sciences" with 43 trials sponsored. Other sponsors include 90 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kapiolani Medical Center for Women and Children" #1 collaborator was "National Cancer Institute (NCI)" with 203 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 126 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "Kapiolani Medical Center for Women and Children" are "Breast Cancer" (23 trials), "Recurrent Neuroblastoma" (12 trials), "Neuroblastoma" (11 trials), "Recurrent Ovarian Carcinoma" (10 trials) and "Recurrent Squamous Cell Lung Carcinoma" (10 trials). Many other conditions were trialed in "Kapiolani Medical Center for Women and Children" in a lesser frequency.

Most popular intervention types in "Kapiolani Medical Center for Women and Children" are "Drug" (304 trials), "Other" (227 trials), "Biological" (124 trials), "Procedure" (89 trials) and "Radiation" (51 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (116 trials), "Quality-of-Life Assessment" (69 trials), "Questionnaire Administration" (62 trials), "Carboplatin" (42 trials) and "Cyclophosphamide" (40 trials). Other intervention names were less common.

The vast majority of trials in "Kapiolani Medical Center for Women and Children" are 320 trials for "All" genders, 74 trials for "Female" genders and 10 trials for "Male" genders.

Currently, there are NaN active trials in "Kapiolani Medical Center for Women and Children". undefined are not yet recruiting, 87 are recruiting, 157 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 124 completed trials in Kapiolani Medical Center for Women and Children, 8 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Kapiolani Medical Center for Women and Children, 16 "Phase 1" clinical trials were conducted, 171 "Phase 2" clinical trials and 180 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 23 trials that are defined as “Not Applicable".